Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Each new occurrence, in turn, fills many with a greater and greater sense of insecurity.This is our new normal—uncertainty ...

In Western Kenya, funerals are not just solemn religious send-offs; they are often grand celebrations of life.This deep-rooted cultural tradition has led to extravagant burial budgets, with families ...

White House press secretary Karoline Leavitt announced that tariffs on Canada and Mexico will begin on February 1, as decided earlier dismissing reports that claimed the tariffs will be deferred ...